《精神分裂症患者治疗转归个人评估量表（PETIT）》的翻译与验证。
Translation and validation of the “personal evaluation of transitions in treatment (PETIT)” scale for people with schizophrenia.
机构信息
CTS-391 Multidisciplinary Group for the progress of Mental Health, Faculty of Nursing and Physiothera- py, University of Cadiz, Spain.
Doctoral Programme, University of Cadiz, Spain.
出版信息
Actas Esp Psiquiatr. 2022 Jan;50(1):27-41. Epub 2022 Jan 1.
Abstract
To adapt the ‘Personal Evaluation of Transitions in Treatment (PETIT)’ scale into Spanish and analyse its psychometric properties on schizophrenic population.
摘要
将“治疗过渡期个人评估量表（PETIT）”改编为西班牙语，并分析其在精神分裂症患者群体中的心理测量学特性。
相似文献
1
Translation and validation of the “personal evaluation of transitions in treatment (PETIT)” scale for people with schizophrenia.《精神分裂症患者治疗转归个人评估量表（PETIT）》的翻译与验证。
Actas Esp Psiquiatr. 2022 Jan;50(1):27-41. Epub 2022 Jan 1.
2
The Swedish version of the Acceptance of Chronic Health Conditions Scale for people with multiple sclerosis: Translation, cultural adaptation and psychometric properties.瑞典版多发性硬化症患者慢性健康状况接受度量表：翻译、文化调适及心理测量特性
J Rehabil Med. 2016 Nov 11;48(10):872-879. doi: 10.2340/16501977-2151.
3
[Adaptation and validation of the MoVac-flu scale on motivation towards the flu vaccine].[MoVac-flu量表在流感疫苗接种动机方面的适应性与验证]
Gac Sanit. 2023 Nov 24;37:102345. doi: 10.1016/j.gaceta.2023.102345. eCollection 2023.
4
A systematic review of the psychometric properties of the cross-cultural translations and adaptations of the Multidimensional Perceived Social Support Scale (MSPSS).多维度感知社会支持量表（MSPSS）跨文化翻译和适应的心理测量特性的系统评价。
Health Qual Life Outcomes. 2018 May 2;16(1):80. doi: 10.1186/s12955-018-0912-0.
5
The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study.《临床总体印象-精神分裂症量表》葡萄牙语版本：验证研究
Braz J Psychiatry. 2007 Sep;29(3):246-9. doi: 10.1590/s1516-44462007000300010.
6
Spanish Adaptation and Validation of the Teaching and Learning Experiences Questionnaire.教学体验问卷的西班牙语改编与验证。
Int J Environ Res Public Health. 2021 Mar 29;18(7):3518. doi: 10.3390/ijerph18073518.
7
Adaptation into Spanish of the Internalised Stigma of Mental Illness scale to assess personal stigma.将精神疾病内化污名量表改编为西班牙语版本以评估个人污名。
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Oct-Dec;11(4):244-254. doi: 10.1016/j.rpsm.2016.01.007. Epub 2016 Mar 9.
8
Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community.社区中精神分裂症患者个人和社会功能量表（PSP）的心理测量学特性。
Qual Life Res. 2008 Dec;17(10):1247-56. doi: 10.1007/s11136-008-9400-z. Epub 2008 Oct 15.
9
Psychometric properties of the Turkish version of Illness Management and Recovery Scale-Patient form.《疾病管理和康复量表-患者形式土耳其语版本的心理测量特性》。
Perspect Psychiatr Care. 2021 Jan;57(1):279-286. doi: 10.1111/ppc.12559. Epub 2020 Jun 17.
10
Development and psychometric properties of a new brief scale for subjective personal agency (SPA-5) in people with schizophrenia.主观个人能动性新简式量表（SPA-5）在精神分裂症患者中的编制及心理测量学特性研究。
Epidemiol Psychiatr Sci. 2020 Apr 10;29:e111. doi: 10.1017/S2045796020000256.
引用本文的文献
1
Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.探索精神分裂症及其药物治疗对健康相关生活质量和治疗偏好的影响。
Patient Prefer Adherence. 2025 Aug 27;19:2647-2661. doi: 10.2147/PPA.S494721. eCollection 2025.
本文引用的文献
1
Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin.使用第二代抗精神病药物治疗的精神分裂症患者的性功能障碍因素：不仅仅是催乳素。
Actas Esp Psiquiatr. 2018 Nov;46(6):217-25. Epub 2018 Nov 1.
2
Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia.埃塞俄比亚中部精神分裂症患者中抗精神病药物治疗的不依从情况
S Afr J Psychiatr. 2018 Mar 5;24:1124. doi: 10.4102/sajpsychiatry.v24i0.1124. eCollection 2018.
3
Influence of sociodemographic and clinical characteristics on the quality of life of patients with schizophrenia.社会人口学和临床特征对精神分裂症患者生活质量的影响。
Rev Esc Enferm USP. 2017 Aug 28;51:e03244. doi: 10.1590/S1980-220X2016031903244.
4
[Empathy, social cognition and subjective quality of life in schizophrenia].[精神分裂症中的同理心、社会认知与主观生活质量]
An Sist Sanit Navar. 2017 Aug 31;40(2):211-219. doi: 10.23938/ASSN.0025.
5
Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.坚持服药可预测精神分裂症的症状和心理社会缓解：社区中患者融入情况的自然研究。
Rev Psiquiatr Salud Ment. 2017 Jul-Sep;10(3):149-159. doi: 10.1016/j.rpsm.2016.04.001. Epub 2016 Jun 10.
6
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.使用鲁拉西酮治疗的患者长期健康相关生活质量改善情况：精神分裂症转换试验开放标签扩展研究的结果
BMC Psychiatry. 2016 Jun 1;16:176. doi: 10.1186/s12888-016-0879-5.
7
Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.针对精神分裂症谱系障碍患者的依从性治疗与常规精神科护理：一项随机对照试验。
BMC Psychiatry. 2016 Feb 25;16:42. doi: 10.1186/s12888-016-0744-6.
8
A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.一种探索精神分裂症患者生活质量决定因素的结构方程建模方法。
Schizophr Res. 2016 Mar;171(1-3):27-34. doi: 10.1016/j.schres.2016.01.012. Epub 2016 Jan 15.
9
Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.基于动机性访谈的依从性疗法对精神分裂症谱系障碍的影响：一项随机对照试验。
Trials. 2015 Jun 14;16:270. doi: 10.1186/s13063-015-0785-z.
10
The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial.阳性与阴性症状量表（PANSS）的精神分裂症严重程度评分与住院风险之间的关系：对CATIE精神分裂症试验的分析。
Schizophr Res. 2015 Aug;166(1-3):110-4. doi: 10.1016/j.schres.2015.05.021. Epub 2015 Jun 2.
Zotero 插件